According to a market report by Lucintel, the future of the global bladder cancer diagnostic market looks promising with opportunities in the hospital, clinic, and cancer center markets. The global bladder cancer diagnostic market is expected to reach an estimated $5 billion by 2030 from $3 billion in 2024 at a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing awareness of bladder related diseases, increasing number of geriatric population, and rising demand for advanced diagnostic technologies like computed tomography scan and magnetic resonance imaging.
A more
than 150-page report to understand trends, opportunity and forecast in global bladder
cancer diagnostic market to 2030 by test type (urine lab tests, cystoscopy, biopsy,
and imaging test), material (transitional cell bladder cancer, squamous cell
bladder cancer, and others), end use industry (hospitals, clinics, cancer
center, and others), and region (North America, Europe, Asia Pacific, and the
Rest of the World).
Lucintel
forecasts that biopsy is expected to witness highest growth over the forecast
period due to its substantial use for effective biopsy technique and advanced
imaging and rising preference for transurethral resection of bladder tumor
approach.
Hospital
will remain the largest segment due to surge in bladder cancer hospitalizations
and substantial availability of healthcare experts in this setting.
Download
sample by clicking on bladder
cancer diagnostic market.
North
America is expected to witness highest growth over the forecast period due to
exisitence of well-established healthcare infrastructure, availability of major
biologics companies, and presence of key players in the region.
Ameritech
Diagnostic Reagent, Bristol-Myers Squibb, Eli Lilly, F. Hofmann-La Roche,
Glaxosmithkline, Novartis International, Pfizer, Abbott, Endo Pharmaceuticals,
Johnson & Johnson are the major suppliers in the bladder cancer diagnostic market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Radiopharmaceutical Theranostics Market
Transcriptomics Technologies Market
E-Motor and Reduction Gearbox Fluid Market
Electric Motorcycle Controller Market
No comments:
Post a Comment